Neural substrates of apathy in Parkinson's disease: A systematic review of structural and functional neuroimaging studies.

BACKGROUND

Apathy is a frequent and disabling non-motor symptom in Parkinson's disease (PD), characterized by diminished motivation, reduced goal-directed behavior, and emotional indifference. Growing evidence suggests that apathy in PD represents a distinct neuropsychiatric syndrome that may coexist with depression and global cognitive impairment, while also showing partially dissociable clinical and neural correlates.

OBJECTIVE

This systematic review aimed to investigate the neural substrates of apathy in PD by synthesizing evidence from structural and functional neuroimaging studies.

METHODS

Following PRISMA guidelines, we searched PubMed, Embase, Web of Science, and Scopus for studies assessing apathy in PD through neuroimaging techniques, including structural MRI, resting-state functional MRI, diffusion tensor imaging, PET/SPECT molecular imaging, and connectivity analyses. Apathy severity was evaluated using validated clinical scales, and findings were compared between PD population with and without apathy, as well as healthy controls.

RESULTS

Across 16 heterogeneous studies, recurrent findings implicated structural, functional, and molecular alterations within fronto-striatal-limbic networks. However, differences in apathy measures and neuroimaging modalities limit direct comparability across studies and do not support a single unified imaging signature of apathy in PD. Apathetic PD subjects consistently exhibited reduced gray matter volume and altered spontaneous activity in the dorsolateral, inferior frontal gyri, anterior cingulate cortex (ACC), and nucleus accumbens, alongside disrupted functional and structural connectivity in fronto-limbic tracts. These alterations were significantly correlated with apathy severity and, in several studies, remained detectable after accounting for depressive symptoms or global cognitive status. Furthermore, the available findings suggest that apathy in PD may involve heterogeneous neurobiological mechanisms, including variable involvement of frontal, striatal, and limbic circuits; however, current evidence remains insufficient to support firm transmitter-based subtyping or treatment stratification.

CONCLUSIONS

Current evidence suggests that apathy in PD involves partially dissociable neural correlates across prefrontal, striatal, and limbic systems. However, methodological heterogeneity across studies limits strong generalization, and future harmonized longitudinal studies are needed to clarify which findings are robust and clinically meaningful.